A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma
2013 ◽
Vol 72
(4)
◽
pp. 815-823
◽
2009 ◽
Vol 28
(1)
◽
1997 ◽
Vol 20
(3)
◽
pp. 242-246
◽
2006 ◽
Vol 24
(4)
◽
pp. 353-357
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 4053-4053
2010 ◽
Vol 29
(6)
◽
pp. 1475-1481
◽